CVE-2024-38817

CVE-2024-38817 is a medium-severity vulnerability with a CVSS 3.x base score of 6.7. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-77.

Key facts

Description

VMware NSX contains a command injection vulnerability.  A malicious actor with access to the NSX Edge CLI terminal may be able to craft malicious payloads to execute arbitrary commands on the operating system as root.

Frequently asked questions

What is CVE-2024-38817?
VMware NSX contains a command injection vulnerability.  A malicious actor with access to the NSX Edge CLI terminal may be able to craft malicious payloads to execute arbitrary commands on the operating system as root.
How severe is CVE-2024-38817?
CVE-2024-38817 has a CVSS 3.x base score of 6.7, rated medium severity. It is exploitable over local access with low attack complexity, requires high privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2024-38817 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (41st percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2024-38817?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2024-38817 have an EU (EUVD) identifier?
Yes. CVE-2024-38817 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-37639.
When was CVE-2024-38817 published?
CVE-2024-38817 was published on 2024-10-09 and last updated on 2026-06-17.

References

Other CWE-77 (Command Injection) vulnerabilities

Browse all CWE-77 (Command Injection) vulnerabilities →